help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pampori, N. A.
Right arrow Articles by Shapiro, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pampori, N. A.
Right arrow Articles by Shapiro, B. H.
Endocrinology Vol. 140, No. 3 1245-1254
Copyright © 1999 by The Endocrine Society


ARTICLES

Gender Differences in the Responsiveness of the Sex-Dependent Isoforms of Hepatic P450 to the Feminine Plasma Growth Hormone Profile1

Nisar A. Pampori2 and Bernard H. Shapiro

Laboratories of Biochemistry, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania 19104-6048

Address all correspondence and requests for reprints to: Dr. Bernard H. Shapiro, Laboratories of Biochemistry, University of Pennsylvania School of Veterinary Medicine, 3800 Spruce Street, Philadelphia, Pennsylvania 19104-6048. E-mail: shapirob{at}vet.upenn.edu

Most of the constitutive hepatic P450 isoforms expressed in the rat exhibit dramatic gender differences. Whereas only male hepatocytes contain CYP2A2, 2C11, and 3A2, only female hepatocytes express CYP2C12 and 3- to 4-fold greater levels of CYP2C7. This sexually dimorphic expression of hepatic P450 isoforms is regulated by the gender-dependent secretory GH profiles, i.e. episodic in males and continuous in females. In the case of the feminine GH profile, the continuous presence of the hormone in the circulation completely suppresses male-specific CYP2A2, 2C11, and 3A2, while stimulating full expression of female-dependent CYP2A1, 2C7, 2C12, and non-P450 testosterone 5{alpha}-reductase (type 1). The gender-dependent expression of the P450s can be reversed by exposing male rats to the continuous feminine plasma GH profile and females to the episodic masculine GH profile. Under these conditions, females will now express the male-specific isoforms and suppress the female-dependent forms, whereas the opposite will occur in the males. Nevertheless, it is not clear whether the levels of expression or suppression are comparable in male and female rats exposed to the same sex-dependent GH profiles. In the present study, we have renaturalized the circulating feminine GH profile in euthyroid-maintained, hypophysectomized female and male rats at six concentrations ranging from 3–100% of normal. Continuous monitoring of GH levels revealed indistinguishable plasma profiles in females and males at each dosage administered. In the case of females, restoration of the feminine-like plasma GH profile at a concentration that was 3% of the normal level restored expression levels (i.e. mRNA, protein, and/or catalytic activity) of female-dependent CYP2C12, 2A1, and 5{alpha}-reductase to 50% or greater of normal and fully suppressed expression of male-specific CYP2A2, 2C11, and 3A2. Twice the dosage of the hormone (6% of normal) was required to restore female-predominant CYP2C7 to 50% of normal in hypophysectomized female rats. In contrast, we found that all of the measured isoforms were significantly less responsive to the inductive and suppressive effects of the feminine-like GH profile when administered to male rats. While suppression of the male-specific isoforms (i.e. CYP2A2, 2C11, and 3A2) in male rats required concentrations of GH in the feminine profile 2–3 times greater than were effective in female rats, no dosage of the hormone was as effective in inducing female-dependent P450s (i.e. CYP2A1, 2C7, and 2C12) in males as in females. Clearly, the continuous feminine GH profile was more effective at inducing and suppressing gender-dependent isoforms of hepatic P450 when restored to female rats, where it is normally secreted, than in males. As GH profiles appear to be the sole factor responsible for regulating the sexually dimorphic expression of hepatic P450 isoforms in adult rats, the differential responsiveness of male and female rats to the feminine GH profile are likely to be inherently induced by irreversible imprinting during a critical developmental period.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
C. Thangavel and B. H. Shapiro
Inherent Sexually Dimorphic Expression of Hepatic CYP2C12 Correlated with Repressed Activation of Growth Hormone-Regulated Signal Transduction in Male Rats
Drug Metab. Dispos., September 1, 2008; 36(9): 1884 - 1895.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. Wauthier and D. J. Waxman
Sex-Specific Early Growth Hormone Response Genes in Rat Liver
Mol. Endocrinol., August 1, 2008; 22(8): 1962 - 1974.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. N. Dhir, C. Thangavel, and B. H. Shapiro
Attenuated Expression of Episodic Growth Hormone-Induced CYP2C11 in Female Rats Associated with Suboptimal Activation of the Jak2/Stat5B and Other Modulating Signaling Pathways
Drug Metab. Dispos., November 1, 2007; 35(11): 2102 - 2110.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. Lin, J. Tang, X. Q. Liu, Y. Jiang, and J. Zheng
Deacetylclivorine: A Gender-Selective Metabolite of Clivorine Formed in Female Sprague-Dawley Rat Liver Microsomes
Drug Metab. Dispos., April 1, 2007; 35(4): 607 - 613.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Thangavel, W. Dworakowski, and B. H. Shapiro
INDUCIBILITY OF MALE-SPECIFIC ISOFORMS OF CYTOCHROME P450 BY SEX-DEPENDENT GROWTH HORMONE PROFILES IN HEPATOCYTE CULTURES FROM MALE BUT NOT FEMALE RATS
Drug Metab. Dispos., March 1, 2006; 34(3): 410 - 419.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. N. Dhir, W. Dworakowski, C. Thangavel, and B. H. Shapiro
Sexually Dimorphic Regulation of Hepatic Isoforms of Human Cytochrome P450 by Growth Hormone
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Wiwi and D. J. Waxman
Role of Hepatocyte Nuclear Factors in Transcriptional Regulation of Male-specific CYP2A2
J. Biol. Chem., February 4, 2005; 280(5): 3259 - 3268.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths, and L. H. Patterson
A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
Drug Metab. Dispos., April 1, 2004; 32(4): 382 - 386.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. N. Dhir and B. H. Shapiro
Interpulse growth hormone secretion in the episodic plasma profile causes the sex reversal of cytochrome P450s in senescent male rats
PNAS, December 9, 2003; 100(25): 15224 - 15228.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. K. Agrawal and B. H. Shapiro
Constitutive and Inducible Hepatic Cytochrome P450 Isoforms in Senescent Male and Female Rats and Response to Low-Dose Phenobarbital
Drug Metab. Dispos., May 1, 2003; 31(5): 612 - 619.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Kalsotra, S. Anakk, C. L. Boehme, and H. W. Strobel
Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats
Drug Metab. Dispos., September 1, 2002; 30(9): 1022 - 1028.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Kaufhold, P. K. Nigam, R. N. Dhir, and B. H. Shapiro
Prevention of Latently Expressed CYP2C11, CYP3A2, and Growth Hormone Defects in Neonatally Monosodium Glutamate-Treated Male Rats by the N-Methyl-D-Aspartate Receptor Antagonist Dizocilpine Maleate
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 490 - 496.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. N. Dhir, W. Dworakowski, and B. H. Shapiro
Middle-Age Alterations in the Sexually Dimorphic Plasma Growth Hormone Profiles: Involvement of Growth Hormone-Releasing Factor and Effects on Cytochrome P450 Expression
Drug Metab. Dispos., February 1, 2002; 30(2): 141 - 147.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. C. Garcia, C. Thangavel, and B. H. Shapiro
Epidermal Growth Factor Regulation of Female-Dependent CYP2A1 and CYP2C12 in Primary Rat Hepatocyte Culture
Drug Metab. Dispos., February 1, 2001; 29(2): 111 - 120.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
N. A. Pampori, A. K. Agrawal, and B. H. Shapiro
Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms
Drug Metab. Dispos., January 1, 2001; 29(1): 8 - 16.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
N. A. Pampori and B. H. Shapiro
Nominal Growth Hormone Pulses in Otherwise Normal Masculine Plasma Profiles Induce Intron Retention of Overexpressed Hepatic CYP2C11 with Associated Nuclear Splicing Deficiency
Endocrinology, November 1, 2000; 141(11): 4100 - 4106.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. K. Agrawal and B. H. Shapiro
Latent Overexpression of Hepatic CYP2C7 in Adult Male and Female Rats Neonatally Exposed to Phenobarbital: A Developmental Profile of Gender-Dependent P450s
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1027 - 1033.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Yamada, M. Yamada, Y. Fujita, T. Nishigami, K. Nakasho, and K. Uematsu
Self-augmentation Effect of Male-specific Products on Sexually Differentiated Progesterone Metabolism in Adult Male Rat Liver Microsomes
J. Biol. Chem., February 9, 2001; 276(7): 4604 - 4610.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society